We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

159 hedge funds and large institutions have $1.02B invested in Taro Pharmaceutical Industries Ltd. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.19M

155% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 33

24% more capital invested

Capital invested by funds: $826M → $1.02B (+$199M)

5% less funds holding

Funds holding: 167 → 159 (-8)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
159
Holders Change
-8
Holders Change %
-4.79%
% of All Funds
4.24%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.13%
New
26
Increased
84
Reduced
33
Closed
31
Calls
$6.99M
Puts
$1.19M
Net Calls
+$5.79M
Net Calls Change
+$6.04M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$40.6M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$20.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.4M
4
BIT
BlackRock Institutional Trust
California
+$15.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$14.9M

Top Sellers

1
GCM
Greywolf Capital Management
New York
-$35.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$8.62M
3
GPC
Guardian Point Capital
Virginia
-$7.16M
4
Morgan Stanley
Morgan Stanley
New York
-$5.21M
5
AL
AJO LP
Pennsylvania
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
MTB
51
Mizuho Trust & Banking
Japan
$3.11M +$1.48M +10,424 +95%
PPA
52
Parametric Portfolio Associates
Washington
$2.85M +$993K +7,004 +56%
CS
53
Credit Suisse
Switzerland
$2.42M +$192K +1,353 +9%
BIM
54
BlackRock Investment Management
Delaware
$2.24M +$1.22M +8,574 +126%
SCM
55
Stevens Capital Management
Pennsylvania
$2.2M +$2.15M +15,136 New
AAM
56
Advisors Asset Management
Colorado
$2.2M -$250K -1,760 -10%
B
57
Bailard
California
$2.19M +$2.13M +15,020 New
NFA
58
Nationwide Fund Advisors
Ohio
$2.12M +$1.71M +12,036 +481%
UBS AM
59
UBS AM
Illinois
$2.08M +$1.57M +11,053 +343%
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$1.91M +$1.29M +9,078 +224%
JP Morgan Chase
61
JP Morgan Chase
New York
$1.85M -$339K -2,389 -16%
Caisse de Depot et Placement du Quebec (CDPQ)
62
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$1.75M +$255K +1,800 +18%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$1.75M +$794K +5,600 +88%
Allianz Asset Management
64
Allianz Asset Management
Germany
$1.73M +$1.34M +9,473 +395%
State of Tennessee, Department of Treasury
65
State of Tennessee, Department of Treasury
Tennessee
$1.73M +$1.68M +11,871 New
Boston Partners
66
Boston Partners
Massachusetts
$1.68M +$132K +931 +9%
Barclays
67
Barclays
United Kingdom
$1.67M +$1.31M +9,231 +411%
ACA
68
Anchor Capital Advisors
Massachusetts
$1.58M -$36.9K -260 -2%
GP
69
GLG Partners
United Kingdom
$1.58M +$569K +4,014 +58%
Nomura Asset Management
70
Nomura Asset Management
Japan
$1.55M +$1.51M +10,680 New
Asset Management One
71
Asset Management One
Japan
$1.51M +$224K +1,583 +18%
TA
72
Teachers Advisors
New York
$1.51M +$799K +5,633 +120%
BlackRock
73
BlackRock
New York
$1.44M +$504K +3,551 +56%
Bank of America
74
Bank of America
North Carolina
$1.41M -$6.24K -44 -0.5%
Capstone Investment Advisors
75
Capstone Investment Advisors
New York
$1.28M +$1.25M +8,801 New
1 2
3
4 5

TARO Hedge Fund Activity: Q2 2016 in Review

159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2016, worth a combined $1.02B — up 24% from $826M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TARO and 26 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 84 added.

The largest buyer was Goldman Sachs, adding an estimated $40.6M. The largest seller was Greywolf Capital Management, exiting entirely with an estimated $35.1M sold.

  • 159 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2016, down from 167 in Q1 2016.
  • Funds reported $1.02B of Taro Pharmaceutical Industries Ltd. stock for Q2 2016, up 24% quarter-over-quarter.
  • 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2016 and 31 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2016 was Goldman Sachs, an estimated $40.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2016 was Greywolf Capital Management, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2016.